Results 121 to 130 of about 900,428 (178)

Sublingual NMN administration increases early circulating terminal catabolites 2PY and 4PY compared with oral administration in healthy adult men. [PDF]

Sci Rep
Wakabayashi J, Higashi S, Morifuji M.
europepmc   +1 more source

In vitro mutagenicity and oral toxicity of newly-manufactured β-nicotinamide mononucleotide

Fundamental Toxicological Sciences
Hidekazu Watanabe, A. Yafune, Takao Sato, Ryota Nakajima, Kunio Nakata   +4 more
semanticscholar   +1 more source

NAD⁺ biology and supplementation: From mechanisms to clinical perspectives. [PDF]

Mol Biol Rep
Pandolfi S, Ghezzi C, Björklund G, Metalla M, Paone FM, Chirumbolo S.   +5 more
europepmc   +1 more source

Systematic Engineering for High-level Production of β-nicotinamide mononucleotide from NAM and Ribose

Food Bioscience
Tianqi Bao, Ping-Ping Weng, Jingfang Wang, Shumei Cui, Yong Tao, Jian-Zhong Huang, Xin-Wei Yang, C. Ke   +7 more
semanticscholar   +1 more source

NAD⁺ metabolism at the host-virus interface. [PDF]

J Gen Virol
Jhandai P, Vaddadi K, Liu L.
europepmc   +1 more source

Nicotinamide Mononucleotide Attenuates Inflammatory Activation, Choroidal Neovascularization, and Lesion-Associated Remodeling. [PDF]

Invest Ophthalmol Vis Sci
Wang J, Osada H, Chen S, Yamaguchi S, Hayashi K, Negishi K, Kurihara T, Ban N.   +7 more
europepmc   +1 more source

Safety and Metabolism-Related Outcomes of Oral Nicotinamide Mononucleotide Supplementation in Adults: A Systematic Review and Meta-Analysis. [PDF]

Nutrients
Yang W, Huang J, Tang Z, Chen C, Sun Y.
europepmc   +1 more source

Nicotinamide Adenine Dinucleotide Augmentation in Diabetic Kidney Disease: Randomized Trial Study Protocol. [PDF]

Kidney Int Rep
Chandra MS, Gagliano-Jucá T, Shekhar S, Pencina KM, Travison TG, Garg R, McDonnell ME, Reid KF, Latham NK, Lam H, Meritus D, Yan Y, Isaza I, Weiss MF, Beleva YM, Bracken EM, Ruiz E, Wang C, Forman J, Waikar SS, Bhasin S.   +20 more
europepmc   +1 more source

Chemical generation of superoxide in the co-presence of riboflavin derivatives and NADH: evidence for a non-enzymatic redox pathway. [PDF]

J Clin Biochem Nutr
Sugita R, Iida S, Nagase M, Masaki H, Yamamoto Y, Fujisawa A.   +5 more
europepmc   +1 more source

Pyrroloquinoline Quinone and NAD⁺ Metabolism in Glaucoma: A Molecular Rationale for Combined Neuroprotection. [PDF]

Pharmaceuticals (Basel)
Medoro A, Davinelli S, Mazzotta CG, Agnifili L, Scapagnini G.   +4 more
europepmc   +1 more source